Psilocybin mushrooms “could prove to be revolutionary in treating depression and become an alternative medication to SSRI”, finds a new study.
Titled Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults – A Systematic Review, the study was published in the journal Clinical Psychopharmacology and Neuroscience. The study was conducted by researchers at Keele University in the United Kingdom.
“Psilocybin is a classical psychedelic which has been utilised for healing purposes for millenia”, notes the study. “However, with its classification as a Schedule I substance, research into this compound is scarce with few FDA-approved clinical studies.”
Continue reading